.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Covington
QuintilesIMS
UBS
Federal Trade Commission
Boehringer Ingelheim
Chubb
Moodys
Healthtrust
Express Scripts

Generated: November 20, 2017

DrugPatentWatch Database Preview

Claims for Patent: 8,288,415

« Back to Dashboard

Claims for Patent: 8,288,415

Title:Pharmaceutical compositions of 3-(4-amino-1-oxoisoindolin-2yl)-piperidine-2,6-dione
Abstract: Substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines are disclosed. The compounds are useful, for example, in reducing the levels of TNF.alpha. in a mammal.
Inventor(s): Muller; George W. (Bridgewater, NJ), Stirling; David I. (Branchburg, NJ), Chen; Roger Shen-Chu (Edison, NJ)
Assignee: Celgene Corporation (Summit, NJ)
Application Number:12/635,637
Patent Claims: 1. A unit dosage form comprising an amount of a compound of the formula: ##STR00007## or an acid addition salt thereof, and a pharmaceutically acceptable carrier, diluent, or excipient, wherein the amount is from 1 mg to 100 mg.

2. The unit dosage form of claim 1, which is a single unit dosage form.

3. The unit dosage form of claim 1, which is adopted for oral administration.

4. The unit dosage form of claim 3, which is in the form of a tablet.

5. The unit dosage form of claim 3, which is in the form of a capsule.

6. A compound of the formula: ##STR00008## or an acid addition salt thereof.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Healthtrust
Baxter
AstraZeneca
Colorcon
Daiichi Sankyo
Medtronic
Express Scripts
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot